STARTUP PROFILE

PIXYL

COUNTRY
France
FOUNDED
2015
CATEGORY
Neuroimaging
Applying FDA-cleared, AI-powered analysis to brain MRI scans, enabling rapid lesion detection and volumetric quantification for neurological care.
Visit website →
Neurofounders Insights
$   Funding   -
Acquired
MODALITY
(f)MRI
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Multi-indication
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
PIXYL is positioned as an AI neuroimaging workflow company, focused on lesion detection and volumetric MRI analysis across neurological care. Its FDA-cleared status makes it a credible clinical software player, though it competes in an increasingly mature imaging-AI market.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
PIXYL
No items found.